Stock listing
PRAX Stock Price, News, Filings & Events — Praxis Precision Medicines, Inc.
Selected listing: PRAX · BOATS · USD · US
This page tracks Praxis Precision Medicines, Inc.'s PRAX:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PRAX:BOATS. PRAX:BOATS is the stock-level entry point for investors researching Praxis Precision Medicines, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Praxis Precision Medicines, Inc. is a public company traded under the ticker PRAX in the American market. The company has a market capitalization of approximately $8.77 billion. Praxis focuses on developing innovative treatments for neurological diseases, aiming to address significant unmet medical needs.
- Ticker
- PRAX:BOATS
- Asset type
- Stock
- Market cap
- $9.63B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- BOATS
- Currency
- USD
Praxis Precision Medicines, Inc. PRAX:BOATS stock context
This page tracks Praxis Precision Medicines, Inc.'s PRAX:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PRAX:BOATS. PRAX:BOATS is the stock-level entry point for investors researching Praxis Precision Medicines, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Praxis Precision Medicines, Inc. is a public company traded under the ticker PRAX in the American market. The company has a market capitalization of approximately $8.77 billion. Praxis focuses on developing innovative treatments for neurological diseases, aiming to address significant unmet medical needs.
Latest news from Praxis Precision Medicines, Inc.
Praxis Precision Medicines to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026
July 30, 2026
Praxis Precision Medicines and Remagine Labs Announce Strategic Collaboration to Develop Transdermal Ulixacaltamide for Essential Tremor
July 7, 2026
Praxis Precision Medicines Announces Extension Period for Relutrigine for Treatment of SCN2A and SCN8A Developmental and Epileptic Enceph...
June 29, 2026
Praxis Precision Medicines Receives FDA Breakthrough Therapy Designation for Elsunersen for the Treatment of Seizures Associated with SCN...
June 22, 2026
Praxis Precision Medicines to Participate in Goldmans Sachs 47th Annual Global Healthcare Conference
June 4, 2026
Praxis Precision Medicines, Inc. earnings calls
Praxis Precision Medicines, Inc. (PRAX) Q2 2026 Earnings Call
August 6, 2026 · Replay with transcript and chapters
Praxis Precision Medicines, Inc. (PRAX) Q1 2026 Earnings Call
May 7, 2026 · Replay with transcript and chapters
Praxis Precision Medicines, Inc. (PRAX) Q4 2025 Earnings Call
February 19, 2026 · Replay with transcript and chapters
Praxis Precision Medicines, Inc. (PRAX) Q2 2025 Earnings Call
August 4, 2025 · Replay with transcript and chapters
Praxis Precision Medicines, Inc. (PRAX) Q3 2024 Earnings Call
November 6, 2024 · Replay with transcript and chapters
Praxis Precision Medicines, Inc. (PRAX) Q2 2024 Earnings Call
August 13, 2024 · Replay with transcript and chapters
Research Praxis Precision Medicines, Inc.
Praxis Precision Medicines, Inc. investor report
Review AI stock analysis and investor report context for PRAX:BOATS.
Praxis Precision Medicines, Inc. company profile
View the public company page for Praxis Precision Medicines, Inc. on 6ix.
Praxis Precision Medicines, Inc. news
Read company news and market updates connected to Praxis Precision Medicines, Inc..
Praxis Precision Medicines, Inc. investor events
Find investor webinars, events, and replay context for Praxis Precision Medicines, Inc..